Henry Schein Inc. ($HSIC) Stock Forecast: Down 0.3% Today

What is Henry Schein Inc.?

Henry Schein Inc. (HSIC) is a leading provider of healthcare products and services, specializing in dental, medical, and technology solutions. The company has a strong global presence and a track record of consistent growth in various sectors.

Why is Henry Schein Inc. going down?

HSIC stock is down 0.3% on May 5, 2026 14:42

• Despite recording strong Q1 2026 financial results, which included a 6.3% increase in sales surpassing analyst expectations, Henry Schein's stock witnessed a slight decline.
• The market's reaction may have been influenced by concerns regarding the company's soft medical business performance and a decrease in adjusted operating margin, despite the overall positive results.
• Investor caution may stem from the modest organic revenue growth and the decrease in free cash flow, leading to a bearish sentiment despite the company's reaffirmed financial guidance and efforts to create value.
• The slight dip in after-hours trading could also be linked to investors taking profits following the positive earnings announcement, contributing to the bearish movement in HSIC stock.

HSIC Price Chart

HSIC Technical Analysis

HSIC News

Transcript: Henry Schein Q1 2026 Earnings Conference Call

Henry Schein reported strong first-quarter 2026 financial results, with global sales reaching $3.4 billion, a 6.3% growth year-over-year. The company saw market share gains in U.S. dental and global technology, offsetting a soft medical business. Henry Schein reiterated its 2026 financial guidance, anticipating high single-digit to low double-digit earnings growth and over $200 million operating income improvement by the end of 2026, driven by continuous improvement and value creation initiatives.

https://www.benzinga.com/insights/news/26/05/52281404/transcript-henry-schein-q1-2026-earnings-conference-call

Henry Schein beats estimates but stock edges down By Investing.com

Henry Schein Inc. reported first-quarter results that surpassed Wall Street expectations with adjusted EPS of $1.32 and revenue of $3.37 billion. Despite the strong performance, the company's shares experienced a slight decline of 0.10% in after-hours trading. Henry Schein reaffirmed its fiscal 2026 adjusted EPS guidance and sales growth expectations, citing continued momentum from the previous year and successful value creation initiatives.

https://ng.investing.com/news/earnings/henry-schein-beats-estimates-but-stock-edges-down-93CH-2481224

Henry Schein (NASDAQ:HSIC) Beats Q1 CY2026 Sales Expectations

Henry Schein (NASDAQ:HSIC) announced better-than-expected Q1 CY2026 results, with sales up 6.3% year-on-year to $3.37 billion, surpassing analyst estimates. The company's non-GAAP profit per share also beat expectations by 8.4%. Despite mixed performance including a decline in free cash flow and a decrease in adjusted operating margin, management reiterated its full-year Adjusted EPS guidance, though organic revenue growth remains modest.

https://www.tradingview.com/news/stockstory:cca1dcd16094b:0-henry-schein-nasdaq-hsic-beats-q1-cy2026-sales-expectations/

Earnings Flash (HSIC) Henry Schein, Inc. Reports Q1 Revenue $3.37B, vs. FactSet Est of $3.34B

Henry Schein, Inc. (HSIC) announced its first-quarter revenue reached $3.37 billion, surpassing the FactSet estimate of $3.34 billion. This financial update indicates a stronger performance than anticipated by analysts for the quarter. The report reaffirms the company's Q1 financial results.

https://www.marketscreener.com/news/earnings-flash-hsic-henry-schein-inc-reports-q1-revenue-3-37b-vs-factset-est-of-3-34b-ce7f58dfd081f122

Henry Schein (NASDAQ: HSIC) Q1 2026 sales up 6.3% as EPS jumps

Henry Schein (NASDAQ: HSIC) reported strong financial results for Q1 2026, with net sales increasing by 6.3% to $3.37 billion and non-GAAP diluted EPS rising 14.8% to $1.32. The company also reaffirmed its 2026 financial guidance, anticipating continued growth in both sales and earnings. Despite a slight decrease in GAAP net income and operating cash flow, Henry Schein is confident in its strategic value creation initiatives aimed at improving operating income significantly over the next few years.

https://www.stocktitan.net/sec-filings/HSIC/8-k-henry-schein-inc-reports-material-event-8dcd08a15266.html

Trending Today

McKesson Corporation ($MCK) Stock Forecast: Down 6.7% Today

CVS Health Corporation ($CVS) Stock Forecast: Up 6.7% Today

Corning Incorporated ($GLW) Stock Forecast: Up 10.9% Today

Uber Technologies Inc. ($UBER) Stock Forecast: Up 6.2% Today

General Electric Company ($GE) Stock Forecast: Up 5.3% Today

QUALCOMM Incorporated ($QCOM) Stock Forecast: Up 7.7% Today

Arista Networks Inc. ($ANET) Stock Forecast: Down 17.7% Today

Lam Research Corporation ($LRCX) Stock Forecast: Up 6.1% Today

Novavax Inc. ($NVAX) Stock Forecast: Up 19.1% Today

Ambarella Inc. ($AMBA) Stock Forecast: Up 5.1% Today

Henry Schein Inc. Price History

24.01.2026 - HSIC Stock was up 9.7%

• Strong fourth-quarter results, surpassing analyst expectations for both earnings and revenue, contributed to the bullish market movement.
• An optimistic fiscal 2026 outlook, forecasting adjusted EPS between $5.23 and $5.37 and total sales growth of 3% to 5%, further fueled investor confidence in the company.
• The positive reception of biosimilars in the healthcare industry may have also boosted sentiment towards Henry Schein, given its involvement in the medical supplies sector.
• The combination of robust financial performance and positive industry trends likely drove the bullish movement in Henry Schein's stock today.

24.01.2026 - HSIC Stock was up 6.7%

• HSIC stock experienced a bullish movement, jumping over 8% following the release of its Q4 earnings report, which beat analyst estimates for both earnings and sales.
• Despite missing EPS estimates, the company's revenue growth across various segments, such as Dental, Medical, Specialty Products, and Technology, contributed to the positive market sentiment.
• The contraction in margins due to increased costs of sales and expenses might be a concern for investors, but the overall strong financial performance and revenue beats likely drove the stock price higher.
• The broader market trend of U.S. stocks seeing gains on Tuesday, coupled with positive quarterly results from multiple companies, contributed to the bullish movement in Henry Schein's stock.

04.10.2025 - HSIC Stock was up 13.7%

• HSIC stock experienced a strong bullish movement today following the release of their Q3 earnings report.
• The earnings and revenue beats by +8.66% and +2.02% respectively have exceeded market expectations, indicating strong performance by the company.
• Investors are likely optimistic about the future prospects of HSIC, as the positive results suggest continued growth and profitability in the healthcare industry.
• The beat in earnings and revenues could attract more investors to the stock, driving up demand and pushing the stock price higher.

04.10.2025 - HSIC Stock was up 10.4%

• HSIC stock saw a surge following the announcement of better-than-expected Q3 earnings and revenue, exceeding analyst estimates by a notable margin.
• Boosting investor confidence, the company's decision to raise its 2025 outlook due to solid business momentum played a significant role in the stock's upward movement.
• The positive surprises in earnings and revenue point towards robust performance and growth potential for Henry Schein, eliciting increased optimism among investors and driving the stock price higher.

25.01.2026 - HSIC Stock was down 6.8%

• A price target increase for Henry Schein to $100 from $90 by Evercore ISI could have initially boosted investor confidence, but the market sentiment shifted bearish despite this positive adjustment.
• Although the company demonstrated strong sales growth in dental and specialty products, concerns about the thin net margin and premium P/E ratio may have led to a bearish movement in the stock.
• The market's response to Henry Schein's better-than-expected fourth-quarter revenue but earnings miss suggests that investors are focusing more on profitability metrics, contributing to the bearish trend.
• The positive financial guidance for 2026 and share repurchase activities might not have been sufficient to offset concerns about the company's profitability and valuation, resulting in the bearish market movement.

15.00.2026 - HSIC Stock was up 3.9%

• The appointment of Frederick M. Lowery, a seasoned executive with a background in the healthcare industry, as the new CEO of Henry Schein has brought a fresh perspective to the company's leadership.
• The strategic shift in leadership, with Stanley M. Bergman transitioning to Chairman, signifies a governance reframe that aims to drive operational efficiencies and growth in specialty products and technology.
• Investors seem optimistic about the potential impact of the new CEO's expertise in distribution and product businesses on Henry Schein's strategic goals, leading to a bullish market movement for the stock.

05.04.2026 - HSIC Stock was down 0.3%

• Despite recording strong Q1 2026 financial results, which included a 6.3% increase in sales surpassing analyst expectations, Henry Schein's stock witnessed a slight decline.
• The market's reaction may have been influenced by concerns regarding the company's soft medical business performance and a decrease in adjusted operating margin, despite the overall positive results.
• Investor caution may stem from the modest organic revenue growth and the decrease in free cash flow, leading to a bearish sentiment despite the company's reaffirmed financial guidance and efforts to create value.
• The slight dip in after-hours trading could also be linked to investors taking profits following the positive earnings announcement, contributing to the bearish movement in HSIC stock.